Pharmabiz

57th GST Council’s recommendations will ease working capital pressures & reduce industry-specific tax costs: Expert

GST Council’s recommendations will ease working capital pressures & reduce industry-specific tax costs: Expert: Nandita Vijayasimha, Bengaluru Monday, October 12, 2026, 08: ...
Pharmabiz

South Indian healthcare market sees structural shift toward preventive and home-based care

South Indian healthcare market sees structural shift toward preventive and home-based care: Peethaambaran Kunnathoor, Chennai Monday, October 12, 2026, 08:00 Hrs [IST] A comprehen ...
Pharmabiz

DoP amends PRIP Scheme to support start-ups and MSMEs developing NCE/NBEs

DoP amends PRIP Scheme to support start-ups and MSMEs developing NCE/NBEs: Gireesh Babu, New Delhi Monday, October 12, 2026, 08:00 Hrs [IST] The Union ministry of chemicals and fe ...
Pharmabiz

DCC rejects proposals on common testing facility and reduced timeline for testing samples

DCC rejects proposals on common testing facility and reduced timeline for testing samples: Gireesh Babu, New Delhi Monday, October 12, 2026, 08:00 Hrs [IST] The Drugs Consultative ...
Pharmabiz

New phase 3b data on Lilly's Taltz and Zepbound advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesity

New phase 3b data on Lilly's Taltz and Zepbound advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesity: Indianapolis Saturda ...
Pharmabiz

New UK-Singapore partnership to accelerate healthcare innovations

New UK-Singapore partnership to accelerate healthcare innovations: United Kingdom Saturday, October 10, 2026, 17:00 Hrs [IST] The NIHR and the National Health Innovation Centre Si ...
Pharmabiz

Agenus’ Botvymo and Evamplix receive marketing authorizations from Republic of Armenia for treatment of metastatic colorectal cancer

Agenus’ Botvymo and Evamplix receive marketing authorizations from Republic of Armenia for treatment of metastatic colorectal cancer: Lexington, Massachusetts Saturday, October ...
Pharmabiz

Vir Biotechnology’s T-cell engager ‘VIR-5500’ gets US FDA’s fast track designation to treat prostate cancer

Vir Biotechnology’s T-cell engager ‘VIR-5500’ gets US FDA’s fast track designation to treat prostate cancer: San Francisco Saturday, October 10, 2026, 15:00 Hrs [IST] Vir ...
Pharmabiz

Newron Pharma updates on US FDA clinical trial hold and phase 3 ENIGMA-TRS development programme

Newron Pharma updates on US FDA clinical trial hold and phase 3 ENIGMA-TRS development programme: Milan, Italy Saturday, October 10, 2026, 14:00 Hrs [IST] Newron Pharmaceuticals S ...
Pharmabiz

bioAffinity Technologies receives Japanese patent for CyPath Lung test to detect lung cancer early

Affinity Technologies receives Japanese patent for CyPath Lung test to detect lung cancer early: San Antonio Saturday, October 10, 2026, 13:00 Hrs [IST] bioAffinity Technologie ...
Pharmabiz

Scholar Rock resubmits marketing authorisation application for apitegromab with EMA to treat children and adults with spinal muscular atrophy

Scholar Rock resubmits marketing authorisation application for apitegromab with EMA to treat children and adults with spinal muscular atrophy: Cambridge, Massachusetts Saturday, O ...
Pharmabiz

US FDA approves Roche’s Tecentriq in combo with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer

US FDA approves Roche’s Tecentriq in combo with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer: Basel Saturday, Octobe ...